by EmpathiCSubstanceS | Feb 2, 2022 | Cancer, Cannabis Marijuana, CBC, Chronic Pain, Cluster Headaches, Depression, DMT, MDMA Sassafras Molly, OCD
From the late 1950s to the early 1970s a novel experimental paradigm was employed to use hallucinogenic drugs to address the existential anxiety, depression and demoralization often experienced by individuals suffering from terminal cancer. In spite of highly...
by EmpathiCSubstanceS | Jan 14, 2022 | Cluster Headaches, Depression, DMT, Kambo, LSD
The main focus on naturally occurring psychedelics has been on a few dozen species identified in North and South America. For example, the Western world knows of roughly 100 species of psychedelic mushrooms. Is this a bias from our bioprospecting or a true...
by EmpathiCSubstanceS | Jan 14, 2022 | Cancer, Cannabis Marijuana, Chronic Pain, Depression, LSD, Neuropathy, Pain, Psychotropics
A first-of-its-kind clinical trial has pitted a common antidepressant against psilocybin, the main psychedelic compound found in magic mushrooms. The results, recently published in the New England Journal of Medicine, are decidedly mixed with the primary depression...
by EmpathiCSubstanceS | Jan 13, 2022 | Chronic Pain, Depression, Iboga, Kambo, LSD, MDMA Sassafras Molly, Pain, Parkinson's Disease
Perhaps one of the most important psychedelic science articles published in 2021 came when psychopharmacologist Suresh Muthukumaraswamy and colleagues Anna Forsythe and Thomas Lumley called out the big elephant in the room of psychedelic clinical trials. The...
by EmpathiCSubstanceS | Jan 13, 2022 | Depression, DMT, Iboga, Kambo, NN-Dimethyltryptamine, Pain, Parkinson's Disease
Cannabis is a remarkably understudied plant containing hundreds of novel molecules, many of which are yet to be scientifically cataloged. This new study set out to investigate what chemicals are responsible for the plant’s characteristic skunk-like smell. The...
